COVID19_BMT Study Open
The IMPACT Clinical Trials Network is excited to collaborate with Dr Giovanna Lucchini at Great Ormond Street Hospital (GOSH) on a study of COVID19 infection in allogenic stem cell recipients
IMPACT is a UK platform for the development, approval and delivery of clinical trials in the field of stem cell transplantation
IMPACT is a partnership of organisations committed to improving the outcomes of stem cell transplant patients through the delivery of clinical trials across the UK. It is jointly funded by Anthony Nolan, Leukaemia UK and NHS Blood and Transplant.
The partnership allows transplant centres across the UK to work together to deliver clinical trials focussed on stem cell transplantation. IMPACT provides funding for research nurses in nine centres, and works with a further thirteen affiliated centres which also participate in IMPACT trials. IMPACT trials are coordinated by the central hub, located at the Cancer Research UK Clinical Trials Unit (CRCTU) at the University of Birmingham.
IMPACT aims to ensure patients benefit from scientific advances sooner by making it easier for transplant centres to work together to set up clinical trials, recruit patients and share data.